ST2825

Effect of ST2825 on the proliferation and apoptosis of human hepatocellular carcinoma cells

Y. Deng, Sun, J., Zhang, L. D., Deng, Y., Sun, J., and Zhang, L. D., Effect of ST2825 on the proliferation and apoptosis of human hepatocellular carcinoma cells, vol. 15, p. -, 2016.

The purpose of this study was to investigate the effect of ST2825, an inhibitor of myeloid differentiation factor 88 (MyD88), on the proliferation and apoptosis of human hepatocellular carcinoma (HCC) cells as well as the potential mechanism and clinical significance of ST2825 in the treatment of HCC. Immunohistochemical staining with an MyD88 antibody was performed on tissues from 80 human HCC patients and adjacent normal tissues.

Subscribe to ST2825